Wray, G. A. The evolutionary significance of cis-regulatory mutations. Nat. Rev. Genet. 8, 206–216 (2007).
Wagner, G. P. & Lynch, V. J. The gene regulatory logic of transcription factor evolution. Trends Ecol. Evol. 23, 377–385 (2008).
Vande Zande, P., Hill, M. S. & Wittkopp, P. J. Pleiotropic effects of trans-regulatory mutations on fitness and gene expression. Science 377, 105–109 (2022).
Sabarís, G., Laiker, I., Preger-Ben Noon, E. & Frankel, N. Actors with multiple roles: pleiotropic enhancers and the paradigm of enhancer modularity. Trends Genet. 35, 423–433 (2019).
Laiker, I. & Frankel, N. Pleiotropic enhancers are ubiquitous regulatory elements in the human genome. Genome Biol. Evol. 14, evac071 (2022).
Singh, D. & Yi, S. V. Enhancer pleiotropy, gene expression, and the architecture of human enhancer-gene interactions. Mol. Biol. Evol. 38, 3898–3909 (2021).
Gasperini, M. et al. A genome-wide framework for mapping gene regulation via cellular genetic screens. Cell 176, 377–390.e19 (2019).
Huang, Y. et al. Two unrelated distal genes activated by a shared enhancer benefit from localizing inside the same small topological domain. Genes Dev. 39, 348–363 (2025).
Wan, J. et al. Comprehensive mapping of genetic variation at Epromoters reveals pleiotropic association with multiple disease traits. Nucleic Acids Res. 53, gkae1270 (2025).
Rajderkar, S. et al. Topologically associating domain boundaries are required for normal genome function. Commun. Biol. 6, 435 (2023).
Halfon, M. S. Studying transcriptional enhancers: the founder fallacy, validation creep, and other biases. Trends Genet. 35, 93–103 (2019).